These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 12370762)
1. Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer. Hayes DF; Walker TM; Singh B; Vitetta ES; Uhr JW; Gross S; Rao C; Doyle GV; Terstappen LW Int J Oncol; 2002 Nov; 21(5):1111-7. PubMed ID: 12370762 [TBL] [Abstract][Full Text] [Related]
2. Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662. Hayes DF; Yamauchi H; Broadwater G; Cirrincione CT; Rodrigue SP; Berry DA; Younger J; Panasci LL; Millard F; Duggan DB; Norton L; Henderson IC; Clin Cancer Res; 2001 Sep; 7(9):2703-11. PubMed ID: 11555582 [TBL] [Abstract][Full Text] [Related]
3. The prognostic and predictive values of circulating HER-2/neu extracellular domain in patients with metastatic breast cancer. Abu-Khalaf MM; Harris L Breast Cancer Res Treat; 2009 Apr; 114(3):513-5. PubMed ID: 18677560 [No Abstract] [Full Text] [Related]
4. Isolation of blood-borne epithelium-derived c-erbB-2 oncoprotein-positive clustered cells from the peripheral blood of breast cancer patients. Brandt B; Roetger A; Heidl S; Jackisch C; Lelle RJ; Assmann G; Zänker KS Int J Cancer; 1998 Jun; 76(6):824-8. PubMed ID: 9626348 [TBL] [Abstract][Full Text] [Related]
5. HER-2/neu status of primary breast cancer and corresponding metastatic sites in patients with advanced breast cancer treated with trastuzumab-based therapy. Pectasides D; Gaglia A; Arapantoni-Dadioti P; Bobota A; Valavanis C; Kostopoulou V; Mylonakis N; Karabelis A; Pectasides M; Economopoulos T Anticancer Res; 2006; 26(1B):647-53. PubMed ID: 16739334 [TBL] [Abstract][Full Text] [Related]
6. Is circulating HER-2 more than just a tumor marker? Baselga J Clin Cancer Res; 2001 Sep; 7(9):2605-7. PubMed ID: 11555569 [No Abstract] [Full Text] [Related]
9. [Serum her-2/neu level and related factors in patients with breast cancer]. Yuan P; Xu BH; Zhang C; Qi J Zhonghua Zhong Liu Za Zhi; 2003 Nov; 25(6):573-4. PubMed ID: 14690565 [TBL] [Abstract][Full Text] [Related]
10. [Serum HER-2 determination using a centauer HER-2/neu kit (CLIA method) in metastatic breast cancer]. Kan N; Yoshikawa S Gan To Kagaku Ryoho; 2009 May; 36(5):779-83. PubMed ID: 19461177 [TBL] [Abstract][Full Text] [Related]
11. The prognostic and predictive values of ECD-HER-2. Hait WN Clin Cancer Res; 2001 Sep; 7(9):2601-4. PubMed ID: 11555568 [TBL] [Abstract][Full Text] [Related]
12. Circulating levels of HER-2/neu oncoprotein in breast cancer. Molina R; Escudero JM; Muñoz M; Augé JM; Filella X Clin Chem Lab Med; 2012 Jan; 50(1):5-21. PubMed ID: 22505536 [TBL] [Abstract][Full Text] [Related]
13. Prediction of response to antiestrogen therapy in advanced breast cancer patients by pretreatment circulating levels of extracellular domain of the HER-2/c-neu protein. Yamauchi H; O'Neill A; Gelman R; Carney W; Tenney DY; Hösch S; Hayes DF J Clin Oncol; 1997 Jul; 15(7):2518-25. PubMed ID: 9215820 [TBL] [Abstract][Full Text] [Related]
14. Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients. Kallergi G; Agelaki S; Kalykaki A; Stournaras C; Mavroudis D; Georgoulias V Breast Cancer Res; 2008; 10(5):R80. PubMed ID: 18822183 [TBL] [Abstract][Full Text] [Related]
15. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA. Yie SM; Luo B; Ye NY; Xie K; Ye SR Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357 [TBL] [Abstract][Full Text] [Related]
16. HER-2/neu diagnostics in breast cancer. Carney WP; Leitzel K; Ali S; Neumann R; Lipton A Breast Cancer Res; 2007; 9(3):207. PubMed ID: 17561991 [TBL] [Abstract][Full Text] [Related]
17. Combination of miR-21 with Circulating Tumor Cells Markers Improve Diagnostic Specificity of Metastatic Breast Cancer. Yang X; Wang X; Shen H; Deng R; Xue K Cell Biochem Biophys; 2015 Sep; 73(1):87-91. PubMed ID: 25669446 [TBL] [Abstract][Full Text] [Related]
18. Correlation between serum HER-2 oncoprotein and patients with breast cancer. Yuan P; Xu BH; Chu DT Chin Med Sci J; 2004 Sep; 19(3):212-5. PubMed ID: 15506651 [TBL] [Abstract][Full Text] [Related]
19. Expression of C-erbB-2/HER-2 in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous blood stem cell support. Bewick M; Chadderton T; Conlon M; Lafrenie R; Morris D; Stewart D; Glück S Bone Marrow Transplant; 1999 Aug; 24(4):377-84. PubMed ID: 10467326 [TBL] [Abstract][Full Text] [Related]
20. Concentration of serum HER-2/neu as a prognostic factor in locally advanced breast cancer (LABC) and metastatic breast cancer (MBC). Purwanto I; Kurnianda J; Hariadi KW; Harijadi ; Aryandono T; Setiaji K; Harianti MS; Haryana SM Acta Med Indones; 2011 Jan; 43(1):23-8. PubMed ID: 21339542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]